|
发表于 12-6-2017 11:15 PM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2017 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Mar 2017 | 31 Mar 2016 | 31 Mar 2017 | 31 Mar 2016 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 30,971 | 0 | 30,971 | 0 | 2 | Profit/(loss) before tax | 4,221 | 0 | 4,221 | 0 | 3 | Profit/(loss) for the period | 3,384 | 0 | 3,384 | 0 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,384 | 0 | 3,384 | 0 | 5 | Basic earnings/(loss) per share (Subunit) | 2.04 | 0.00 | 2.04 | 0.00 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.5700 | 0.5700
|
|
|
|
|
|
|
|
|
发表于 17-7-2017 01:46 AM
|
显示全部楼层
主攻国内禽畜业.龙马跃持续成长
随着人口的增加,粮食需求也自然增加,而禽畜业所需的医疗保健需求也肯定会尾随上涨的趋势,从事动物医疗保健终端方案供应商兼食品材料供应商——龙马跃(RHONEMA,5278,主板贸服组)也自然可从中受惠,且听该公司董事经理林万强解析该行业未来的走势。
林万强接受《投资致富》专访时表示,大马主要的禽畜业者,与公司都有业务上的来往,而这些客户不断扩大业务,如鸡蛋及鸡肉的产能,这些都是驱动公司成长的原因。
病情及瘟疫是禽畜领域最害怕的事项,因为遇上这些无法预测的灾难,对禽畜业者,无疑是重锤的打击。但林万强表示,瘟疫的发生,反而是营业额大增的机会,因为禽畜业者需要更多的药物,以预防疫情加深。
“当疫情发生时,即使该区需要销毁所有禽畜及隔离消毒,禽畜业者不能停下业务,将另寻觅地,在其他地方养殖,新的养殖区,依旧需要药物控制,以避免疫情发生。原本养殖的瘟疫地区,只需隔离几个月,确认安全后,就可重新启用了,药物自然不可缺少。”
林万强坦言,虽然瘟疫可为公司带来更好的营收,但瘟疫并非是公司所期望的事,毕竟这对环境生态并不好。
“预防胜于治疗,每当疫情解决以后,业者会有更强的危机意识,进行更多的预防工作。”
服务较全面有优势
询及利基市场方面,林万强自豪表示,全马约有80多家同侪,但龙马跃所提供的服务相当全面,是较为优势的地方。
龙马跃提供的服务包括禽畜健康解决、研发、制造及自家品牌。旗下品牌包括,Rhomicosin、Rhonanox、Rholyte及Nystatin FG等等。
“其他同侪提供的服务可能只有疫苗销售,却没有自己的研发中心。”
林万强以养鸡业为例,传统上,鸡只注射疫苗,需要手把手,逐只为小鸡注射疫苗,但公司研发的设备,有助于业者节约更多时间。
“我亲自试过该设备,一小时内,至少可为1500只小鸡注射疫苗。”
除了禽畜保健品需求外,龙马跃亦提供其他植物性的原料服务。
大型食品商洽合作
林万强表示,公司希望可以做到更多的跨行业销售,以分化风险。
“公司目前供应薯粉及面筋给饼干及面包工厂。
目前,正在与大马大型食品业者洽谈合作事宜。”
有关龙马跃的命名,林万强说,龙马跃前身为Rhodia,是法国公司,后来,Rhodia母公司进行企业重组,Rhodia提供优惠,让他们进行管理层收购(Mangement Buy Out)后,为了纪念前公司的帮助,因此在名字上没有太大更动,而“马”字则代表马来西亚。
处成长期派息未定
询及派息政策方面,林万强坦言,以当下市场营运而言,具备庞大的成长潜能,而公司需要更多资金用以发展业务,因此短期内不会制定派息政策。
“公司正处于成长期,因此我们不能制定派息政策。”
放眼海外营收增
针对厂房建造方面,林万强说,汝来正在建造的厂房预期年杪可竣工,届时饲料、疫苗等产能可从636万吨最多可提高至4倍的产能。
林万强亦表示,海外贡献公司250万令吉的营业额,约3%左右,放眼海外营业额可持续获得成长。
2016年12月,龙马跃在马股上市,共募集3159万令吉,其中2450万令吉用于资本开销,截至今年3月31日为止,龙马跃已经使用了946万令吉。
文章来源:
星洲日报‧投资致富‧企业故事‧文:谢汪潮‧2017.07.16 |
|
|
|
|
|
|
|
发表于 2-8-2017 02:55 AM
|
显示全部楼层
本帖最后由 icy97 于 3-8-2017 05:21 AM 编辑
龙马跃559万巴生买厂
2017年8月3日
(吉隆坡2日讯)龙马跃控股(RHONEMA,5278,主板贸服股)以总值558万8000令吉,向KlangGroup发展有限公司,收购位于巴生的半独立式工厂。
该公司昨日向交易所报备,通过独资子公司龙马跃(马)有限公司,购买使用面积达1万4616平方尺的永久地契厂房,内有1座仓库和2层办公楼。
交易是由内部融资与银行贷款来支付,估计3个月内完成,而负债将从去年杪的0.06倍,增加至0.11倍,但不会影响截至12月杪的财年净利。
“这收购符合未来发展,扩大食材的储藏库;工厂地理位置优越,连接数条高速公路。”【e南洋】
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | RHONE MA HOLDINGS BERHAD ("RMH" OR "THE COMPANY")- ACQUISITION OF A FACTORY LOCATED IN DAERAH KLANG, SELANGOR DARUL EHSAN BY RHONE MA MALAYSIA SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF RMH | The Board of Directors of the Company wishes to announce that Rhone Ma Malaysia Sdn. Bhd., a wholly-owned subsidiary of the Company, had on 1 August 2017 entered into a Sale and Purchase Agreement with Klanggroup Development Sdn. Bhd. (Company No. 1014494-X) for the acquisition of a semi-detached factory comprising one (1) mezzanine (store) and two (2)-storey office, bearing postal address known as No. 21, Jalan Wawasan 2C/KU7, Sungai Kapar Indah, 42200 Klang, Selangor Darul Ehsan for an aggregate cash consideration of RM5,588,000.00.
This announcement is dated 1 August 2017. | http://www.bursamalaysia.com/market/listed-companies/company-announcements/5504309
|
|
|
|
|
|
|
|
发表于 23-8-2017 02:30 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2017 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Jun 2017 | 30 Jun 2016 | 30 Jun 2017 | 30 Jun 2016 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 33,126 | 0 | 64,097 | 0 | 2 | Profit/(loss) before tax | 4,313 | 0 | 8,534 | 0 | 3 | Profit/(loss) for the period | 3,443 | 0 | 6,827 | 0 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,443 | 0 | 6,827 | 0 | 5 | Basic earnings/(loss) per share (Subunit) | 2.07 | 0.00 | 4.11 | 0.00 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.5900 | 0.5700
|
|
|
|
|
|
|
|
|
发表于 9-11-2017 05:17 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)Particulars of Substantial Securities HolderName | MR TAN LEONG ANN | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Date of cessation | 08 Nov 2017 | Name & address of registered holder | Tan Leong Ann828-P Lorong Zamrud 1Taman Kerjasama SatuBukit Beruang75450 Melaka |
No of securities disposed | 38,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Cessation of interest due to disposal of shares | Nature of interest | Direct Interest | | Date of notice | 08 Nov 2017 | Date notice received by Listed Issuer | 08 Nov 2017 |
|
|
|
|
|
|
|
|
发表于 22-11-2017 04:50 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2017 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2017 | 30 Sep 2016 | 30 Sep 2017 | 30 Sep 2016 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 37,189 | 28,835 | 101,286 | 87,911 | 2 | Profit/(loss) before tax | 4,393 | 4,642 | 12,927 | 14,204 | 3 | Profit/(loss) for the period | 3,508 | 3,777 | 10,335 | 11,223 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,508 | 3,643 | 10,335 | 11,006 | 5 | Basic earnings/(loss) per share (Subunit) | 2.11 | 2.94 | 6.23 | 8.88 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.6000 | 0.5700
|
|
|
|
|
|
|
|
|
发表于 19-12-2017 04:04 AM
|
显示全部楼层
本帖最后由 icy97 于 22-12-2017 02:59 AM 编辑
停销部分Merial产品
龙马跃明年业绩看跌
2017年12月13日
(吉隆坡12日讯)龙马跃控股(RHONEMA,5278,主板贸服股)接获修订协议,停止分销跨国动物保健公司Merial的部分产品,并预计2018财年业绩将受到冲击。
龙马跃控股今日向交易所报备,独资子公司Rhone Ma(马)私人有限公司(简称RMM),于上周五(8日)接获修订协议,就早前与Merial签署的分销协议作出修正,更换产品分销清单。
按照修正协议,新产品清单将不包括分销猪、家禽、反刍动物和兽医公共保健品。目前,RMM是Merial产品的分销商,产品包括猪、家禽、如牛羊等反刍动物和宠物伴侣,以及兽医公共保健品。
这意味着,修改分销协议后,RMM只会继续分销Merial的宠物伴侣产品。
不影响今年净利
龙马跃控股称,修订协议对2017财年的净利影响不大,但会对2018财年带来负面冲击,因为这些被排除在外的产品销售,在2016财年分别贡献总营业额和税前盈利31.54%和47.44%。
为了缓解负面财务影响,该公司会与其他主要国际动物健康产品供应商合作,助分销家禽、猪和反刍动物的产品。
营销团队也会加大力度推销其他产品,尤其是内部制造产品。
龙马跃控股还说,一旦新厂房和符合“生产质量规范”(GMP)的新厂完成和投运,将能增加自家动物保健产品的产量和销售。【e南洋】
Type | Announcement | Subject | OTHERS | Description | RHONE MA HOLDINGS BERHAD ("RMH" OR "COMPANY")- REVISION OF PRODUCT LIST TO EXCLUDE SWINE, POULTRY, RUMINANT AND VETERINARY PUBLIC HEALTH PRODUCTS OF MERIAL SOCIETE PAR ACTIONS SIMPLIFIEE ("MERIAL") | The Board of Directors of RMH (“Board”) wishes to announce that Rhone Ma Malaysia Sdn Bhd (“RMM”), a subsidiary of RMH, had on 12 December 2017, received a signed amendment dated 8 December 2017 to the distribution agreement dated 7 November 2000 between RMM and Merial (as amended on 31 July 2001, 31 January 2003, 6 June 2003 and 23 July 2014) to replace the current products list with a new products list which excludes swine, poultry, ruminant and veterinary public health products (“Excluded Products”) (“Amendment”).
Currently, RMM is the distributor of Merial products comprising products for swine, poultry, ruminant and companion animals as well as veterinary public health products. Pursuant to the Amendment, RMM will continue to distribute companion animal products of Merial. In respect of the Excluded Products, Merial or its affiliate or any nominated designated third party shall be entitled in its sole discretion to repurchase the remaining inventory of the Excluded Products in the possession of RMM which meets the criteria specified in the Amendment.
In the event where Merial decided not to repurchase the Excluded Products, Merial shall inform RMM in writing and RMM shall use its best efforts:
(i) to sell all remaining inventory of the excluded swine, veterinary public health and ruminant products for the period up to 31 December 2017; and
(ii) to sell all remaining inventory of the excluded poultry products for the period up to 30 March 2018.
Notwithstanding the above, in the event that RMM, despite its best efforts, is not able to sell the remaining inventory as stated in (i) and (ii) above, Merial or its affiliate or any nominated designated third party shall have the sole discretion to purchase the remaining unsold inventory of the Excluded Products in the possession of RMM which meets the criteria specified in the Amendment at the price in accordance with the product list annexed to the Amendment.
In addition, RMM shall, as required and/or when requested by Merial, continue importation and sell the Excluded Products as annexed to the Amendment, up to when the marketing authorisation and/or all regulatory assignments and product registrations for the Excluded Products are successfully transferred to Merial and/or to its nominated third party.
The Amendment is not expected to have any material impact on the earnings of the Group for the financial year ending 31 December 2017 but is expected to have a negative financial impact to the Group for the financial year ending 31 December 2018 as the sale of the Excluded Products supplied by Merial collectively contributed approximately 31.54% and 47.77% of the total revenue and profit before taxation (excluding the one-off charge of listing expenses which amounted to approximately RM4.14 million) of the Group for the financial year ended 31 December 2016, respectively.
Notwithstanding the above, the Board is of the view that the negative financial impact would be mitigated by the following:
(i) the Company will explore options with other major international suppliers of animal health products for the distribution of their products for poultry, swine and ruminants;
(ii) the sales and marketing team will increase their efforts to market and sell other products particularly the in-house manufactured products; and
(iii) the Company will enhance its sales and marketing efforts to expand its market share in regional markets which have growth potential.
The Company also anticipates that upon the completion and operation of its new warehouse and GMP-compliant plant, the Company will be able to increase the volume of production and sales of its own animal health products.
This announcement is dated 12 December 2017. |
|
|
|
|
|
|
|
|
发表于 3-1-2018 01:19 AM
|
显示全部楼层
本帖最后由 icy97 于 3-1-2018 04:22 AM 编辑
龙马跃分销法国CEVA产品
2018年1月3日
(吉隆坡2日讯)龙马跃控股(RHONEMA,5278,主板贸服股)签署分销协议,获得法国兽医医药公司在大马的独家分销权。
龙马跃控股今日向交易所报备,独资子公司Rhone Ma(马)私人有限公司(简称RMM),昨日与CEVA Sante Animal S.A.和CEVA Animal Health(马)私人有限公司签约。
根据分销协议,RMM将负责在大马分销、推广和销售与猪相关的“CEVA”动物保健品,期限为1月1日至2020年12月31日。
抵消停销Merial损失
龙马跃控股称,上述协议会贡献集团2018财年的净利和每股净资产,并抵消之前因停止分销跨国动物保健公司Merial的猪产品,而造成营业额损失的影响。
CEVA Sante Animal S.A.是一家国际机构,主要涉及研究、发展、生产和营销陪伴动物、家禽、反刍动物和猪的医药产品及疫苗,业务涉足45个国家。【e南洋】
Type | Announcement | Subject | OTHERS | Description | RHONE MA HOLDINGS BERHAD ("RMH" OR "COMPANY")- EXECUTION OF DISTRIBUTION AGREEMENT BETWEEN RHONE MA MALAYSIA SDN BHD (A WHOLLY-OWNED SUBSIDIARY OF RMH), CEVA SANTE ANIMALE S.A. AND CEVA ANIMAL HEALTH MALAYSIA SDN BHD | The Board of Directors of RMH (“Board”) wishes to announce that Rhone Ma Malaysia Sdn Bhd (“RMM”), a wholly-owned subsidiary of RMH, had on 1 January 2018, signed a distribution agreement with CEVA Sante Animale S.A. and CEVA Animal Health Malaysia Sdn Bhd (collectively referred to as “CEVA”) for the exclusive distribution of CEVA’s animal health products related to swine listed in the agreement (“Distribution Agreement with CEVA”). CEVA Sante Animale S.A. is an international corporation engaged in research, development, production and marketing of pharmaceutical products and vaccines for companion animal, poultry, ruminant and swine with presence in 45 countries.
The Distribution Agreement with CEVA allows RMM to distribute, promote and sell CEVA’s animal health products related to swine in Malaysia. The Distribution Agreement with CEVA is valid for a period with effect from 1 January 2018 until 31 December 2020. The Distribution Agreement with CEVA shall be renewed and continue in full force and effects for a successive periods of 1 year unless and until either party gives to the other written notice of termination at least 3 months prior to the end of the initial term or any successive one-year period.
The Distribution Agreement with CEVA will have no effect on the issued and paid-up capital of the Company and is not expected to have any material impact on the earnings of RMH and its subsidiaries (“Group”) for the financial year ended 31 December 2017 as the Distribution Agreement with CEVA will only be effective from 1 January 2018. It is expected to contribute positively towards the Group's earnings and net assets per share for the financial year ending 31 December 2018. The contribution from the Distribution Agreement with CEVA is expected to mitigate the impact of the loss of revenue from the cessation of distribution of swine products from RMM’s previous supplier.
None of the Directors or substantial shareholders of RMH or person connected with them have any interest, whether direct or indirect, in the aforesaid Distribution Agreement with CEVA.
The Board is of the opinion that the Distribution Agreement with CEVA is in the best interest of RMH.
This announcement is dated 2 January 2018. |
|
|
|
|
|
|
|
|
发表于 16-1-2018 02:36 AM
|
显示全部楼层
EX-date | 25 Jan 2018 | Entitlement date | 29 Jan 2018 | Entitlement time | 05:00 PM | Entitlement subject | Interim Dividend | Entitlement description | Interim Single Tier Dividend of 2.5 sen per ordinary share for the financial year ended 31 December 2017 | Period of interest payment | to | Financial Year End | 31 Dec 2017 | Share transfer book & register of members will be | to closed from (both dates inclusive) for the purpose of determining the entitlement | Registrar or Service Provider name, address, telephone no | BOARDROOM CORPORATE SERVICES (KL) SDN BHDLot 6.05, Level 6, KPMG Tower8, First AvenueBandar Utama47800 Petaling JayaSelangor Darul EhsanTel:0377201188Fax:0377201111 | Payment date | 13 Feb 2018 | a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers | 29 Jan 2018 | b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit |
| c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange. | Number of new shares/securities issued (units) (If applicable) |
| Entitlement indicator | Currency | Currency | Malaysian Ringgit (MYR) | Entitlement in Currency | 0.025 |
|
|
|
|
|
|
|
|
发表于 14-2-2018 03:51 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | Rhone Ma Holdings Berhad ("RMH" or "the Company")- Incorporation of a New Sub Subsidiary Company, APSN Healthcare & Diagnostics Sdn. Bhd. | The Company wishes to announce that Asia-Pacific Special Nutrients Sdn. Bhd., a wholly-owned subsidiary of the Company had on 13 February 2018, incorporated a wholly owned subsidiary known as APSN Healthcare & Diagnostics Sdn. Bhd. (“APHD”) under the Companies Act 2016.
The intended principal activity of APHD are to provide test and diagnostics services for human healthcare, conduct research and development in biotechnology and distribution of human healthcare and related products.
The above incorporation does not have any effect on the issued and paid-up share capital of the Company and has no material effect on the earnings and net assets of the Company and its subsidiaries for the financial year ending 31 December 2018.
None of the directors and/or substantial shareholders of the Company, or persons connected to such director and/or substantial shareholder has any interest, direct or indirect, in the said incorporation.
This announcement is dated 13 February 2018. |
|
|
|
|
|
|
|
|
发表于 27-2-2018 06:18 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2017 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Dec 2017 | 31 Dec 2016 | 31 Dec 2017 | 31 Dec 2016 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 36,202 | 31,284 | 137,488 | 119,195 | 2 | Profit/(loss) before tax | 4,135 | -984 | 17,062 | 13,220 | 3 | Profit/(loss) for the period | 3,583 | -1,840 | 13,918 | 9,383 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,583 | -1,840 | 13,918 | 9,166 | 5 | Basic earnings/(loss) per share (Subunit) | 2.15 | -1.47 | 8.38 | 7.31 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.6200 | 0.5700 |
|
|
|
|
|
|
|
|
发表于 3-4-2018 04:12 AM
|
显示全部楼层
本帖最后由 icy97 于 3-4-2018 06:25 AM 编辑
Type | Announcement | Subject | OTHERS | Description | RHONE MA HOLDINGS BERHAD ("RMH" OR "THE COMPANY")- EXECUTION OF DISTRIBUTION AGREEMENT BETWEEN RHONE MA MALAYSIA SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF RMH) AND ZOETIS MALAYSIA SDN. BHD. | The Board of Directors of RMH (“Board”) wishes to announce that Rhone Ma Malaysia Sdn. Bhd. (“RMM”), a wholly-owned subsidiary of RMH, had on 1 April 2018, entered into a distribution agreement with Zoetis Malaysia Sdn. Bhd. (“ZMSB”) for the distribution of ZMSB’s animal health products related to poultry listed in the agreement (“Distribution Agreement”).
The Distribution Agreement allows RMM to distribute ZMSB’s animal health products related to poultry in Malaysia and is effective from 1 April 2018 for a period of 3 years, unless terminated earlier pursuant to the terms of the Distribution Agreement. Thereafter, it shall be automatically extended for a further period of 1 year subject to the terms of the Distribution Agreement (“Extension Term”) and the parties may further extend the term of the Distribution Agreement by providing written notice prior to the expiration of the Extension Term on mutually agreed new terms and conditions.
The Distribution Agreement with ZMSB will have no effect on the issued and paid-up capital of the Company. The distribution of new poultry products in accordance with the Distribution Agreement will contribute to the revenues of RMM, which in turn is expected to contribute positively towards the earnings and net assets per share of RMH and its subsidiaries for the financial year ending 31 December 2018.
None of the Directors or substantial shareholders of RMH or person connected with them have any interest, whether direct or indirect, in the aforesaid Distribution Agreement.
The Board is of the opinion that the Distribution Agreement is in the best interest of RMH.
About ZMSB: ZMSB is a subsidiary company of Zoetis Inc. (“ Zoetis”). Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2017, the company generated annual revenue of USD$5.3 billion with approximately 9,000 employees. For more information, visit www.zoetis.com.
This announcement is dated 2 April 2018. |
|
|
|
|
|
|
|
|
发表于 1-5-2018 06:39 AM
|
显示全部楼层
EX-date | 26 Jun 2018 | Entitlement date | 28 Jun 2018 | Entitlement time | 04:00 PM | Entitlement subject | Final Dividend | Entitlement description | Final Single-Tier Dividend of 2.5 sen per ordinary share in respect of the financial year ended 31 December 2017 | Period of interest payment | to | Financial Year End | 31 Dec 2017 | Share transfer book & register of members will be | to closed from (both dates inclusive) for the purpose of determining the entitlement | Registrar or Service Provider name, address, telephone no | BOARDROOM CORPORATE SERVICES (KL) SDN BHDLot 6.05, Level 6, KPMG Tower8, First AvenueBandar Utama47800Petaling JayaTel:0377201188Fax:0377201111 | Payment date | 13 Jul 2018 | a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers | 28 Jun 2018 | b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit |
| c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange. | Number of new shares/securities issued (units) (If applicable) |
| Entitlement indicator | Currency | Currency | Malaysian Ringgit (MYR) | Entitlement in Currency | 0.025 |
|
|
|
|
|
|
|
|
发表于 26-5-2018 03:46 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2018 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Mar 2018 | 31 Mar 2017 | 31 Mar 2018 | 31 Mar 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 41,941 | 30,971 | 41,941 | 30,971 | 2 | Profit/(loss) before tax | 4,135 | 4,221 | 4,135 | 4,221 | 3 | Profit/(loss) for the period | 3,265 | 3,384 | 3,265 | 3,384 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,265 | 3,384 | 3,265 | 3,384 | 5 | Basic earnings/(loss) per share (Subunit) | 1.97 | 2.04 | 1.97 | 2.04 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.6100 | 0.6200
|
|
|
|
|
|
|
|
|
发表于 23-6-2018 07:31 AM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 22-8-2018 02:53 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2018 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Jun 2018 | 30 Jun 2017 | 30 Jun 2018 | 30 Jun 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 29,318 | 33,126 | 71,259 | 64,097 | 2 | Profit/(loss) before tax | 2,619 | 4,313 | 6,754 | 8,534 | 3 | Profit/(loss) for the period | 2,206 | 3,443 | 5,471 | 6,827 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 2,206 | 3,443 | 5,471 | 6,827 | 5 | Basic earnings/(loss) per share (Subunit) | 1.33 | 2.07 | 3.30 | 4.11 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.6300 | 0.6200
|
|
|
|
|
|
|
|
|
发表于 29-8-2018 02:31 AM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 18-11-2018 07:27 AM
|
显示全部楼层
本帖最后由 icy97 于 20-11-2018 02:00 AM 编辑
龙马跃10送1红股
http://www.enanyang.my/news/20181109/龙马跃10送1红股/
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
BONUS ISSUES | Description | RHONE MA HOLDINGS BERHAD ("RMH" OR "COMPANY") PROPOSED BONUS ISSUE OF UP TO 16,600,000 NEW ORDINARY SHARES IN RMH ("RMH SHARE(S)") ("BONUS SHARE(S)") ON THE BASIS OF 1 BONUS SHARE FOR EVERY 10 EXISTING RMH SHARES HELD ON AN ENTITLEMENT DATE TO BE DETERMINED LATER ("PROPOSED BONUS ISSUE") | On behalf of the Board of Directors of RMH, Public Investment Bank Berhad wishes to announce that RMH is proposing to undertake the Proposed Bonus Issue. Further details on the Proposed Bonus Issue are set out in the attachment.
This announcement is dated 8 November 2018. | http://www.bursamalaysia.com/market/listed-companies/company-announcements/5968737
|
|
|
|
|
|
|
|
发表于 2-12-2018 06:18 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2018 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2018 | 30 Sep 2017 | 30 Sep 2018 | 30 Sep 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 33,346 | 37,189 | 104,605 | 101,286 | 2 | Profit/(loss) before tax | 3,540 | 4,393 | 10,294 | 12,927 | 3 | Profit/(loss) for the period | 2,308 | 3,508 | 7,779 | 10,335 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 2,308 | 3,508 | 7,779 | 10,335 | 5 | Basic earnings/(loss) per share (Subunit) | 1.39 | 2.11 | 4.69 | 6.23 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.6100 | 0.6200
|
|
|
|
|
|
|
|
|
发表于 15-1-2019 06:22 AM
|
显示全部楼层
EX-date | 03 Jan 2019 | Entitlement date | 07 Jan 2019 | Entitlement time | 05:00 PM | Entitlement subject | Bonus Issue | Entitlement description | Bonus issue of up to 16,600,000 new ordinary shares in Rhone Ma Holdings Berhad ("RMH") ("RMH Shares") ("Bonus Shares") on the basis of 1 Bonus Share for every 10 existing RMH Shares held at 5.00 p.m. on 7 January 2019 ("Entitlement Date") ("Bonus Issue") | Period of interest payment | to | Financial Year End |
| Share transfer book & register of members will be | to closed from (both dates inclusive) for the purpose of determining the entitlement | Registrar or Service Provider name, address, telephone no | Symphony Share Registrars Sdn BhdLevel 6, Symphony HousePusat Dagangan Dana 1Jalan PJU 1A/4647301 Petaling JayaSelangor Darul EhsanTel: 03-7841 8088/8099Fax: 03-7841 8100 | Payment date |
| a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers | 07 Jan 2019 | b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit |
| c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange. | Number of new shares/securities issued (units) (If applicable) |
| Entitlement indicator | Ratio | Ratio | 1 : 10 |
|
|
|
|
|
|
|
| |
本周最热论坛帖子
|